Piramal Enterprises – Q3 Note

Q3 in cr Pharma and Manufacturing Financial Services Information Management Unallocated Total Capital Employed 3221 9202 4293 (4607) 12110 Revenue 802 219 377 1398 Profits as reported -5 162 132 47 346 Profits without exceptional -5-2+34-18=9 162 132 47 350 Finance Cost -95 PBT 241 The Pharma and Manufacturing business has finally turned cash positive,…

Read More